| 摘要 |
<p>The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II, and methods for the treatment of peptic ulcers and gastrointestinal diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of duodenal ulcers, esophageal ulcers, gastric ulcers, Meckel's diverticulum ulcers, gastroesophageal ulcers, Type I to Type V gastroesophageal ulcers, gastric reflux disease (GERD), peptic ulcers, gastrointestinal bleeding, inflammation, irritable bowel disease, Crohn's disease, gastritis, pancreatitis, stomach cancer, cholesystitis and hepatic congestion.</p> |
